Bright! FRONTEO Official Blog

Bright! FRONTEO Official Blog

[Held on September 9th!14th Economic Security Study Group] "Economic Security in the Health and Medical Field" -Introduction of Supply Chain Analysis Cases of Pharmaceutical Companies Utilizing FRONTEO AI

Nov. 2022, 8
This seminar will discuss economic security in the health crisis arena.
The novel coronavirus has had a major impact on the world.
While countries are competing fiercely to secure strategic goods and acquire important technologies, vaccines and therapeutic drugs are the core of the "strategic goods" that countries around the world have been fighting over.
Active pharmaceutical ingredients (APIs) are mainly manufactured in China and India, and we rely on China for many raw materials.
Important technologies and items in the health crisis area change dynamically even in the middle of the crisis, depending on the content of the threat, supply and demand in the market, and the degree of dependence on a specific country. and armed attack situations pose a national crisis.
In order to protect the lives and health of the people, we will explain how to prepare and respond to economic security in the "health crisis" area.

【Webinar Summary】

◆ Theme: "Economic security in the health and medical field" -Introduction of supply chain analysis cases of pharmaceutical companies using FRONTEO AI

◆ Date: September 2022, 9 (Wednesday) 14: 15-00: 16
◆ Webinar type: Zoom Webinar
◆ Participation conditions: For companies
Participants from the same industry, individuals, and free e-mail addresses are not allowed to participate.
For details of the study session here

Photo_Yoshiyuki Sagara full.jpgInternational House of Japan
Senior Research Fellow, Asia Pacific Initiative (API) and Senior Research Fellow, Institute of Geoeconomics (IOG) 
Yoshiyuki Sagara 
Worked at a think tank after working for a private company, the United Nations, and the Ministry of Foreign Affairs.His research interests include foreign and security policy, economic security, sanctions, international conflict, and health security. DeNA Co., Ltd. (DeNA) from 2005 to 2011; Rural Development Department, Japan International Cooperation Agency (JICA) from 2012 to 2013; International Organization for Migration (IOM) Sudan from 2013 to 2015; Policy and Mediation Department, Political Affairs Bureau, United Nations Secretariat (NY Headquarters) until 2015;He graduated from the Faculty of Law, Keio University, and completed the Graduate School of Public Policy, the University of Tokyo.
Authors include "Corona Response in Japan as Crisis Management", "Asteion" No. 94 (May 2021), "New Corona Response/Private Extraordinary Investigation Committee (Corona Private Inquiry) Investigation and Verification Report" (co-author, 5) October 2020), etc. He served as the secretariat for the "Corona Private Inquiry," which examined Japan's response to the coronavirus in the first half of 10, and co-authored the chapters on border control, border measures, the official residence, and therapeutic drugs and vaccines in the investigation and verification report.The Corona private investigation report will also be published in English in 2020.
FRONTEO Inc. Director/ AI Solution Business Management and President's Office Manager
Mari Yamamoto
After joining an advertising agency, he was enrolled in a risk management company.Launched the mental health care business, executed business plans, product development, marketing and sales strategies, and led the company to the top market share in the industry. Appointed as a director in 2014 and listed on the First Section of the Tokyo Stock Exchange in 2017.
Participated in FRONTEO in 2018, became a director in 2020, and is in charge of and directs the president's office and the entire AI solution business.
In the life science AI business, we promoted the development of diagnostic support, disease prediction, and drug discovery support AI systems using the artificial intelligence engine "Concept Encoder", and directed the launch of the world's first medical device using language analysis AI.Take on the challenge of new areas in life science.
In the business intelligence business, we utilize the artificial intelligence engine "KIBIT" to support corporate DX promotion.In the field of economic security as well, we are advocating a change in consciousness together with experts and researchers, and developing intelligence-based solutions for governments, government agencies, and companies.Help companies make strategic decisions with a fact-based approach.
As a top company in the field of natural language analysis, he plans and directs the growth strategy of the AI ​​solution business.

Articles in the same category

Commonly viewed articles

ja 日本語
Machine Translation by Google. : close x